People · Operator
Named in public records as an officer, director or promoter · active 2008–2025 · Software / Tech, Other Technology, Biotechnology, Telecommunications, Pharmaceuticals, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| ABL Space Systems Co | — | Software / Tech | Series D+ | $480.3M | $537.4M | 2021 |
| Glydways, Inc. | — | Other Technology | Series D+ | $200.4M | $869.7M | 2023 |
| Svelte Medical Systems Inc | — | Biotechnology | Series C | $113.1M | $163.8M | 2021 |
| Vascular Therapies Inc | — | Biotechnology | Series B | $89.2M | $471.9M | 2015 |
| Achronix Semiconductor Corp | — | Other Technology | Series C | $79.1M | $183.5M | 2008 |
| Dali Systems Co. Ltd. | — | Telecommunications | Series B | $53.4M | $419.2M | 2011 |
| Bioscale Inc | — | Biotechnology | Series B | $44.7M | $747.7M | 2012 |
| Ferric, Inc. | — | Other Technology | Series B | $41.1M | $209.4M | 2024 |
| BioVex Group, Inc. | — | Biotechnology | Series B | $38.0M | $749.5M | 2009 |
| Juventas Therapeutics Inc | — | Biotechnology | Series B | $35.8M | $52.0M | 2008 |
| Trellis Bioscience Inc | — | Biotechnology | Series A | $23.4M | $8.5M | 2011 |
| Phase Four, Inc. | — | Other Technology | Series A | $23.1M | $57.7M | 2021 |
| Ralexar Therapeutics, Inc. | — | Pharmaceuticals | Series A | $19.0M | $132.5M | 2014 |
| Lightwire Inc | — | Other Technology | Series A | $14.0M | $388.4M | 2011 |
| Pakal Technologies, Inc. | — | Software / Tech | Series A | $13.3M | $10.0M | 2021 |
| PerceptiMed, Inc. | — | Other Technology | Series A | $11.0M | $57.3M | 2013 |
| Resolve Therapeutics LLC | — | Other Health Care | Series A | $8.9M | $117.7M | 2011 |
Somu Subramaniam at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Somu Subramaniam on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Friedman | 2 | 9 |
| ROBERT CROCE | 2 | 7 |
| Somasundaram Subramaniam | 2 | 5 |
| Robert Flanagan | 2 | 4 |
| Suzette Dutch | 2 | 3 |
| Vinod Khosla | 1 | 12 |
| Amit Shah | 1 | 10 |
| Stewart Alsop | 1 | 10 |
| Isaac Cheng | 1 | 9 |
| William F. Doyle | 1 | 8 |
| Stephen Tullman | 1 | 7 |
| Ethan Batraski | 1 | 7 |
| Jason Martin | 1 | 7 |
| Andrew Midler | 1 | 6 |
| Robert Fischell | 1 | 6 |
| Paul Ferris | 1 | 6 |
| Jay Shah | 1 | 6 |
| George Arida | 1 | 6 |
| David Fischell | 1 | 6 |
| Neal Walker | 1 | 5 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.